Laboratory testing for cytomegalovirus among pregnant women in the United States: a retrospective study using administrative claims data

BMC Infectious Diseases

Research Article

Scott D Grosse¹  Michael J Cannon¹  Jessica Leung²  Stephanie R Bialek² 

[1] National Center for Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, 30333, Atlanta, GA, USA;National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, 30333, Atlanta, GA, USA;

关键词: CMV;    Cytomegalovirus;    MarketScan;    Pregnant women;    Screening;    Laboratory testing;   

DOI  :  10.1186/1471-2334-12-334

 received in 2012-06-20, accepted in 2012-11-23,  发布年份 2012

来源: Springer

【 摘 要 】

BackgroundRoutine cytomegalovirus (CMV) screening during pregnancy is not recommended in the United States and the extent to which it is performed is unknown. Using a medical claims database, we computed rates of CMV-specific testing among pregnant women.MethodsWe used medical claims from the 2009 Truven Health MarketScan® Commercial databases. We computed CMV-specific testing rates using CPT codes.ResultsWe identified 77,773 pregnant women, of whom 1,668 (2%) had a claim for CMV-specific testing. CMV-specific testing was significantly associated with older age, Northeast or urban residence, and a diagnostic code for mononucleosis. We identified 44 women with a diagnostic code for mononucleosis, of whom 14% had CMV-specific testing.ConclusionsFew pregnant women had CMV-specific testing, suggesting that screening for CMV infection during pregnancy is not commonly performed. In the absence of national surveillance for CMV infections during pregnancy, healthcare claims are a potential source for monitoring practices of CMV-specific testing.

【 授权许可】

CC BY   
© Leung et al.; licensee BioMed Central Ltd. 2012